LPL Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.24M Sell
48,228
-258
-0.5% -$22.7K ﹤0.01% 2443
2025
Q1
$4.42M Sell
48,486
-8,887
-15% -$810K ﹤0.01% 2246
2024
Q4
$4.95M Sell
57,373
-35,154
-38% -$3.03M ﹤0.01% 2083
2024
Q3
$8.79M Buy
92,527
+5,225
+6% +$497K ﹤0.01% 1549
2024
Q2
$7.99M Sell
87,302
-5,991
-6% -$548K ﹤0.01% 1505
2024
Q1
$8.46M Buy
93,293
+24,580
+36% +$2.23M ﹤0.01% 1440
2023
Q4
$5.59M Buy
68,713
+2,964
+5% +$241K ﹤0.01% 1615
2023
Q3
$5.25M Buy
65,749
+24,850
+61% +$1.98M ﹤0.01% 1564
2023
Q2
$3.22M Sell
40,899
-3,704
-8% -$292K ﹤0.01% 1858
2023
Q1
$3.46M Sell
44,603
-65,952
-60% -$5.12M ﹤0.01% 1741
2022
Q4
$8.59M Buy
110,555
+37,806
+52% +$2.94M 0.01% 1111
2022
Q3
$4.89M Buy
72,749
+30,770
+73% +$2.07M ﹤0.01% 1392
2022
Q2
$3.23M Buy
41,979
+22,802
+119% +$1.75M ﹤0.01% 1677
2022
Q1
$1.53M Buy
19,177
+571
+3% +$45.6K ﹤0.01% 2244
2021
Q4
$1.43M Buy
18,606
+2,409
+15% +$185K ﹤0.01% 2345
2021
Q3
$1.18M Buy
16,197
+17
+0.1% +$1.24K ﹤0.01% 2474
2021
Q2
$1.18M Buy
16,180
+2,875
+22% +$210K ﹤0.01% 2425
2021
Q1
$918K Buy
13,305
+2,670
+25% +$184K ﹤0.01% 2458
2020
Q4
$707K Sell
10,635
-974
-8% -$64.8K ﹤0.01% 2455
2020
Q3
$722K Sell
11,609
-375
-3% -$23.3K ﹤0.01% 2171
2020
Q2
$746K Buy
11,984
+2,899
+32% +$180K ﹤0.01% 2056
2020
Q1
$494K Sell
9,085
-465
-5% -$25.3K ﹤0.01% 2110
2019
Q4
$613K Sell
9,550
-146
-2% -$9.37K ﹤0.01% 2193
2019
Q3
$553K Sell
9,696
-2,260
-19% -$129K ﹤0.01% 2178
2019
Q2
$701K Sell
11,956
-2,278
-16% -$134K ﹤0.01% 1984
2019
Q1
$864K Sell
14,234
-768
-5% -$46.6K ﹤0.01% 1744
2018
Q4
$822K Buy
15,002
+897
+6% +$49.1K ﹤0.01% 1673
2018
Q3
$908K Buy
14,105
+628
+5% +$40.4K ﹤0.01% 1729
2018
Q2
$795K Buy
13,477
+288
+2% +$17K ﹤0.01% 1780
2018
Q1
$750K Sell
13,189
-907
-6% -$51.6K ﹤0.01% 1812
2017
Q4
$836K Sell
14,096
-708
-5% -$42K ﹤0.01% 1656
2017
Q3
$855K Sell
14,804
-1,091
-7% -$63K ﹤0.01% 1542
2017
Q2
$939K Sell
15,895
-299
-2% -$17.7K ﹤0.01% 1412
2017
Q1
$884K Buy
16,194
+44
+0.3% +$2.4K 0.01% 1337
2016
Q4
$862K Sell
16,150
-55
-0.3% -$2.94K 0.01% 1320
2016
Q3
$928K Buy
16,205
+399
+3% +$22.8K 0.01% 1257
2016
Q2
$937K Sell
15,806
-14,924
-49% -$885K 0.01% 1218
2016
Q1
$1.76M Buy
30,730
+2,980
+11% +$171K ﹤0.01% 1276
2015
Q4
$1.79M Buy
27,750
+14,361
+107% +$928K 0.01% 1242
2015
Q3
$861K Buy
13,389
+104
+0.8% +$6.69K ﹤0.01% 1348
2015
Q2
$946K Sell
13,285
-662
-5% -$47.1K ﹤0.01% 1410
2015
Q1
$967K Sell
13,947
-317
-2% -$22K ﹤0.01% 1375
2014
Q4
$917K Buy
14,264
+1,170
+9% +$75.2K 0.01% 1369
2014
Q3
$823K Buy
13,094
+1,120
+9% +$70.4K ﹤0.01% 1403
2014
Q2
$743K Buy
11,974
+2,520
+27% +$156K ﹤0.01% 1531
2014
Q1
$552K Buy
9,454
+2,586
+38% +$151K ﹤0.01% 1665
2013
Q4
$365K Sell
6,868
-281
-4% -$14.9K ﹤0.01% 1965
2013
Q3
$345K Buy
7,149
+2,460
+52% +$119K ﹤0.01% 1909
2013
Q2
$213K Buy
+4,689
New +$213K ﹤0.01% 2161